1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Aesthetic Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Aesthetic Devices Market, United States 9
3.1 Aesthetic Devices Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Aesthetic Fillers Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Aesthetic Implants Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.2 Aesthetic Devices Market, United States, Volume (Units), 2015-2025 15
3.2.1 Aesthetic Fillers Market, United States, Volume (Units), by Segment, 2015-2025 17
3.2.2 Aesthetic Implants Market, United States, Volume (Units), by Segment, 2015-2025 19
3.3 Aesthetic Devices Market, United States, Average Price ($), 2015-2025 21
3.4 Aesthetic Devices Market, United States, Distribution Share by Revenue ($m), 2019 23
3.5 Aesthetic Devices Market, United States, Company Share by Revenue ($m), 2019 24
4 Overview of Key Companies in United States, Aesthetic Devices Market 26
4.1 Allergan Ltd 26
4.1.1 Company Overview 26
4.2 Mentor Worldwide LLC 26
4.2.1 Company Overview 26
4.3 Merz Pharma GmbH & Co KgaA 26
4.3.1 Company Overview 26
4.4 Galderma SA 27
4.4.1 Company Overview 27
4.5 Boston Scientific Corp 27
4.5.1 Company Overview 27
4.6 Sientra Inc 27
4.6.1 Company Overview 27
4.7 Coloplast A/S 28
4.7.1 Company Overview 28
5 Aesthetic Devices Market Pipeline Products 29
6 Financial Deals Landscape 30
6.1 Equity Offerings 30
6.1.1 Cutera Raises USD28.8 Million in Public Offering of Shares 30
6.1.2 SANUWAVE Health Raises USD2.25 Million in Private Placement of Series C Convertible Preferred Stock 32
6.1.3 Establishment Labs Raises USD69 Million in Public Offering of Shares 33
6.1.4 Misonix Prices Public Offering of Shares for USD30 Million 35
6.1.5 NanoVibronix Files Registration Statement for Public Offering of Securities for up to USD11.9 Million 37
6.1.6 InMode Aesthetic Solutions May Raise Funds through Public Offering of Shares 39
6.1.7 Avita Medical Raises USD15.4 Million in Private Placement of Shares 40
6.1.8 InMode Aesthetic Solutions Underwriters Exercise of Over-Allotment Option of IPO of Shares for USD77 Million 41
6.1.9 NanoVibronix Raises USD3.2 Million in Private Placement of Convertible Preferred Stock 43
6.2 Partnerships 44
6.2.1 Suneva Medical Enters into Partnership with Sinclair Pharma 44
6.3 Private Equity 45
6.3.1 Clayton, Dubilier & Rice Acquires Cynosure from Hologic for USD205 Million 45
6.4 Venture Financing 47
6.4.1 Suneva Medical Raises USD25.1 Million in Venture Financing 47
6.4.2 Suneva Medical Raises USD5 Million in Venture Financing 48
6.4.3 Surgical Innovation Associates Raises USD4 Million in Series A Financing 49
6.4.4 Suneva Medical Raises USD2.5 Million in Venture Financing 50
7 Recent Developments 51
7.1 Corporate Communications 51
7.1.1 Mar 12, 2020: Plus Therapeutics welcomes two new Directors 51
7.1.2 Feb 06, 2020: Plus Therapeutics appoints Chief Financial Officer 51
7.1.3 Feb 06, 2020: Plus Therapeutics announces changes to its Board of Directors 52
7.1.4 Jan 07, 2020: Dyve Biosciences announces Chuck Harbert, Ph.D. to join as Chief Scientific Officer 52
7.1.5 Jan 02, 2020: Plus Therapeutics appoints Dr. An van Es-Johansson to board of directors 52
7.1.6 Dec 10, 2019: Sciton’s recent User Summit Held in Dallas broke new records 53
7.1.7 Dec 09, 2019: Diane Gomez-Thinnes appointed as worldwide president of mentor 54
7.1.8 Nov 18, 2019: Cutera appoints Fuad Ahmad as Interim CFO 55
7.1.9 Nov 13, 2019: Bausch + Lomb And TerraCycle announce donation of new custom training modules incorporating used contact lens Materials to Guide Dog Foundation 55
7.1.10 Nov 12, 2019: Merz forms fully focused global medical aesthetics business: Merz Aesthetics 56
7.1.11 Oct 24, 2019: Aspen Laser receives award from Global Health & Pharma 57
7.1.12 Aug 16, 2019: Merz announces key governance changes 57
7.1.13 Aug 12, 2019: Cutera announces planned retirement of David B. Apfelberg, M.D., as member of the board of directors 58
7.1.14 Jul 24, 2019: AirXpanders announces board changes 59
7.1.15 Jul 09, 2019: Cutera announces appointment of David Mowry as Chief Executive Officer 59
7.2 Financial Announcements 60
7.2.1 Feb 26, 2020: Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results 60
7.2.2 Feb 12, 2020: CHF solutions expands commercial presence in Europe with distribution arrangement for Germany, Austria and Switzerland 61
7.2.3 Jan 28, 2020: Establishment Labs announces preliminary results for fourth quarter and full year 2019; reports record revenue 62
7.2.4 Jan 13, 2020: Misonix reports preliminary fiscal 2020 second quarter revenue of approximately $19.7 million 62
7.2.5 Jan 12, 2020: Cutera announces preliminary financial results for fourth quarter and full-year 2019 63
7.2.6 Nov 15, 2019: SANUWAVE health reports third quarter 2019 financial results 63
7.2.7 Nov 07, 2019: Cutera reports third quarter 2019 financial results 65
7.2.8 Sep 23, 2019: MOCA I acute heart attack data to be presented at TCT19 66
7.2.9 Aug 15, 2019: SANUWAVE Health reports second quarter 2019 financial results 67
7.2.10 Aug 14, 2019: Misonix reports fourth quarter and fiscal year 2019 results 69
7.2.11 Aug 08, 2019: Cutera reports second quarter 2019 financial results 71
7.3 Legal And Regulatory 72
7.3.1 Mar 10, 2020: Cutera claims Lutronic stole trade secrets 72
7.3.2 Dec 16, 2019: Bausch Health Resolves "Stock Drop" Litigation initially filed in October 2015 73
7.3.3 Oct 30, 2019: SANUWAVE successfully completes extensive round of quality system and technical file audits 73
7.3.4 Jul 16, 2019: Candela and Lumenis announce settlement of patent infringement lawsuit 74
7.3.5 Jun 20, 2019: SEC investigation of Misonix ends with no action 74
7.4 Other Significant Developments 75
7.4.1 Feb 24, 2020: AbbVie announces extension of expiration date for exchange offers for Allergan notes 75
7.4.2 Dec 16, 2019: Eclipse obtains major quality and regulatory milestone 75
7.5 Product News 76
7.5.1 Dec 04, 2019: Cartessa Aesthetics releases Subnovii Plasma Technology to the US Marketplace 76
7.5.2 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 76
7.5.3 Oct 17, 2019: Dyve Biosciences to present at the 2019 BIO Investor Forum 77
7.5.4 Oct 03, 2019: Dyve Biosciences to highlight the power and potential of transdermal drug delivery at PODD 2019 77
7.6 Strategy And Business Planning 77
7.6.1 Feb 03, 2020: Candela to market MT.DERM's medical microneedling products 77
7.6.2 Nov 21, 2019: Hologic to divest Cynosure medical aesthetics unit for $205m 78
7.6.3 Nov 12, 2019: BD submits Pre-Market approval supplement to FDA for BD Onclarity HPV Test with extended genotyping capabilities 78
8 Appendix 80
8.1 Research Methodology 81
8.1.1 Coverage 81
8.1.2 Secondary Research 81
8.1.3 Primary Research 82
8.1.4 Market Modeling and Forecasting 83
8.1.5 Company Share Analysis 85
8.1.6 Distribution Share Analysis 85
8.1.7 Benchmarking 85
8.2 GlobalData Consulting 86
8.3 Contact Us 86
8.4 Disclaimer 87